Status
Conditions
Treatments
About
The present study aims to collect data regarding the history of the disease, previous and current treatments, and the clinical status of Dravet patients during the 3 months prior to stiripentol initiation, the first 3 months on stiripentol and the last 3 months on stiripentol (irrespective of stiripentol discontinuation).
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Carine FRANCOIS, PharmD; Roxane NOËL, PharmD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal